ABSTRACT. The effect of hypoxia on plasma met-enkephalin and catecholamine levels was studied in chronically catheterized fetal sheep. Maternal and fetal hypoxia was maintained for 20 min. We found hypoxia significantly increased the plasma levels of large mol wt met-enkephalin containing peptides from 1755 f 229 pg/mL during baseline to 4408 + 1426 pg/mL by 15 minutes of hypoxia. The levels of the met-enkephalin pentapeptide were unchanged during hypoxia from a baseline value of 168 f 56 pg/mL. Norepinephrine and epinephrine levels increased 5-and 10-fold, respectively, by 15 min of hypoxia. These observations suggest cosecretion of the large mol wt met-enkephalin peptides with catecholamines during stress in developing animals. (Pediatr Res 27: 52-55, 1990) Abbreviations MET-ENK, methionine-enkephalin LEU-ENK, leucine enkephalin MET-ENKi, methionine enkephalin immunoreactivity iments to measure the circulating plasma levels of the MET-ENK peptides in fetal sheep in response to hypoxia.
gestation (term = 150 d). The ewes were sedated preoperatively with ketamine (800 mg) and atropine (1.2 mg) and received a constant infusion of ketamine (8-10 mg/min) during the operation. The fetal hindleg was exteriorized through a uterine incision. After local anesthesia of the fetal leg (1 % lidocaine), polyvinyl catheters were placed in an artery and vein and advanced to the level of the descending aorta and the inferior vena cava, respectively. An additional catheter was placed in the uterus to allow measurement of amniotic fluid pressure. The uterine incision was closed with all catheters tunneled subcutaneously in the maternal flank and stored in a cloth pouch sewn to the skin of the ewe. The ewe also had catheters placed into the femoral vein and artery that were tunneled subcutaneously and stored with the fetal catheters. Oxacillin and gentamycin were given intravenously for 3 d postoperatively to both mother and fetus. Animals were allowed to recover a minimum of 5 d before anv studies were performed. The opiate peptides (endorphins and enke~halins) have been Experimental protocol. Fetal studies were carried out between shown to have significant physiologic effects on autonomic re-122 and 125 d of gestation. On the day of study, the fetal arterial sponses of fetal and neonatal cardiovascular (1) and respiratory catheter and the intrauterine pressure catheters were connected systems (2, 3) in humans and animals. The enke~halin peptides to Statham P23dB pressure transducers that were attached to a are ~ostulated to influence these systems centrally (41, as well as Sensormedics R6 1 1 rectilinear polygraph (Sensormedics Corpo~eri~herally, by inhibitory effects on neurotransmission in sYm-ration, Anaheim, CA). Fetal arterial blood gases and hematocrit pathetic ganglia (5, 6) and on adrenal medullary cat~cholamine were obtained. Arterial blood pressure, heart rate, and amniotic release (7) . fluid pressure were monitored and allowed to stabilize for 30 The enkephalins have been localized in brainstem nuclei in-,in before experimental manipulation. volved in autonomic regulation, sympathetic neurons and sym~~r i~~ the resting baseline period, duplicate arterial blood pathetic ganglia, intestinal neurons and ganglia, and in chromaf-samples were obtained for measurement of plasma MET-ENK, fin granules of the adrenal medulla (8) (9) (10) . In the adrenal chro-epinephrine, norepinephrine, and arterial blood gas analysis. mafin cells, they are found costored with catecholamines as Resting baseline measurements of arterial blood pressure and pentapeptides, MET-ENK, LEU-ENK, and as larger mO1 wt fetal heart rate were also recorded. Fetal arterial pressure was forms, including carboxy-extended f~r m s MET-ENK and the corrected by subtraction of the measured amniotic fluid pressure. enkephalin prohormone (9, 10) . In vitro and in situ studies show ~f~~~ the baseline measurements, hypoxia was produced by all forms of the enkephalins are secreted with catecholamines in a bag over the ewe's head and delivering a response to a variety of stimuli (9, 11) . gas mixture of nitrogen and oxygen to maintain an Fi02 in the here have been few studies on the secretion of enke~halin range of 10-12%. The fetal Pao2 was monitored and the oxygen peptides in intact, unanesthetized developing animals. Important delivery was adjusted to maintain the fetal Pao2 between 12 and maturational effects on fetal and neonatal catecholamine secre-14 mm H~.
tion have been described (12, 13 blood was removed at each sampling period and was replaced 5 3 with heparinized maternal blood obtained before experimental manipulation.
The arterial blood for MET-ENK analysis was placed into chilled test tubes containing sodium citrate (12 mM final concentration). The blood for catecholamine analysis was placed into chilled tubes containing EGTA [4 mM, (ethylene glycol bis (P-amino-ethyl ether) N,N,NIN'-tetra acetic acid)] and reduced glutathione (3 mM). The samples were centrifuged immediately and the plasma was separated and stored at -70°C until analysis was performed.
Analytical techniques. Plasma for measurement of MET-ENK was first extracted through polystyrene columns (14) and then measured by RIA using commercial antiserum (Immunoclear, Stillwater, MN). This antiserum cross-reacts 2.8% with leuenkephalin. Thus all measurements represent MET-ENKi. Plasma for measurement of the high rnol wt enkephalin peptides or total MET-ENKi first underwent sequential proteolytic digestion with trypsin and carboxypeptidase B as previously described (1 1). The plasma was then extracted and measured with RIA as described above. The assay was sensitive to 2.3 + 0.3 pg. The inter-and intrassay variability were 13 and 9%, respectively. Recovery of MET-ENK using this technique was determined to be more than 90% after 1000, 500, or 200 pg/mL additions to unextracted plasma. All enkephalin samples from each study period were extracted, digested, and measured in the same assay. Catecholamines were measured by a radioenzymatic assay sensitive to 1-2 pg of norepinephrine and epinephrine as previously described (1 5).
To characterize the plasma MET-ENK immunoreactivity, plasma was subjected to gel filtration. Unextracted pooled fetal plasma was applied to a Sephadex G-75 column (0.9 x 57 cm) equilibrated with 1 N acetic acid and eluted at 0.5 mL/min. Fractions of 1 mL were collected and dried in a vacuum evaporator and then assayed for MET-ENK. A second aliquot of the fetal plasma was separated on the same Sephadex column and fractions were collected identically. After vacuum evaporation, samples were subjected to trypsin and carboxypeptidase B digestion before extraction and assay for MET-ENK by RIA. This second aliquot represents total MET-ENKi (high rnol wt enkephalin peptides). This procedure was repeated in triplicate using pooled fetal plasma before and after hypoxia.
Data analysis. Data are presented as mean and SEM. The catecholamine data was log transformed prior to statistical analysis and the values are presented as the geometric mean f SEM. Analysis of variance was used for statistical comparisons during hypoxia and Dunnett's test was used to compare data during hypoxia to the baseline data. A p value <0.05 was considered statistically significant.
RESULTS
The paired samples for catecholamines, enkephalin peptides, and the biophysical data before hypoxia were not statistically different and were combined and are presented as baseline values. The data in Table 1 show the biophysical measurements made during the baseline period and during hypoxia in the fetal sheep. The fetal Paoz decreased to a mean value of 14 k 0.3 mm Hg at 20 min from a baseline value of 24 k 1 mm Hg. There was a small increase in systolic blood pressure and a significant decrease in fetal heart rate during hypoxia. Systemic pH was not statistically different during the short duration of hypoxia. Baseline control values for the MET-ENK peptides, norepinephrine, and epinephrine are shown in Figures 1 and 2 . The baseline values for the circulating MET-ENK plasma levels show the higher rnol wt forms of enkephalins (total MET-ENKi) predominant with mean baseline levels of 1755 versus 168 pg/mL for MET-ENKi (the low rnol wt peptides). The baseline values for norepinephrine and epinephrine levels were similar to data previously reported by our laboratory and others (16, 17) and were believed to represent healthy, nonstressed animals.
Norepinephrine and epinephrine were significantly elevated during hypoxia to maximum values of 2582 + 366 and 676 + 73 1 pg/mL, respectively, by 15 min of hypoxia (Fig. 1) . As seen in Figure 2 , circulating plasma levels of total MET-ENKi were significantly increased during hypoxia with a mean of 4408 k 1426 pg/mL during the 15-min sampling period versus the baseline value of 175 5 pg/mL. The pentapeptide (MET-ENKi) levels were not statistically different during hypoxia from baseline values of 168 pg/mL.
Control experiments for the effects of time and sampling procedure were carried out on two additional animals. A clear plastic bag was placed over the head of the ewe and she was allowed to breathe room air. Using the same sampling times and blood vol, we drew blood from the fetus for catecholamine and enkephalin peptide analysis and replaced it with an equal vol of heparinized maternal blood. Although these animals were at an older gestational age (132 and 137 d), we found no significant changes in fetal plasma enkephalin peptides MET-ENKi or total MET-ENKi) from baseline values of 162 + 22 and 2886 k 364 pg/mL, respectively. Similarly, there were no statistically significant changes from baseline values for norepinephrine (835 -+ 180 pg/mL), epinephrine (35 a 10 pg/mL), systolic blood pressure (61 k 3 mm Hg), heart rate (169 + 10 bpm), or fetal arterial blood gas values.
The gel filtration results are shown in Figure 3 . As can be seen, the plasma immunoreactivity designated MET-ENKi coeluted precisely with MET-ENK standard. Plasma first separated by gel filtration and then subjected to trypsin and carboxypeptidase B, yielded the profile designated total MET-ENKi. As can be seen, the total MET-ENKi elution profile extended over a broad range. Plasma protein substrates of a rnol wt range from 17 000 to 80 000 yielded MET-ENKi when subjected to the digestion procedure. There was no difference in the rnol wt profiles from pooled plasma obtained before or after initiation of hypoxia.
DISCUSSION
In this study, we investigated the effects of hypoxia on circulating levels of both MET-ENK and catecholamines in fetal sheep. We noted a significant increase in the large rnol wt forms of enkephalins when fetal sheep were exposed to significant but brief periods of hypoxia. We noted also a significant increase in the circulating levels of catecholamines and a physiologic response of the fetus to hypoxia with a significant degree of bradycardia. In contrast to the large rnol wt enkephalin peptide response to hypoxia, we noted no change in the pentapeptide MET-ENKi.
There is limited in vivo data on the circulating levels of MET-ENK in animals exposed to physiologic stress. Increased levels of the circulating MET-ENK pentapeptides have been described in adult dogs and cats exposed to hypovolemia (18, 19) . In dogs exposed to hypoglycemia, increased levels of the large rnol wt peptides have been described with no change noted in the pentapeptide levels (20) .
The enkephalin peptides are found costored as pentapeptides and as larger rnol wt forms with catecholamines in adrenal medullary chromaffin cells (9, 10) . Review of enkephalin peptide content in adrenal medullary cells suggest as little as 10% of the total enkephalin equivalents are stored as the pentapeptides (10) . All forms of these peptides are coreleased with catecholamines from the adrenal gland during physiologic stimuli in situ (1 1, 21) . Furthermore, studies suggest a differential release of the enkephalin peptides, with small amounts of low rnol wt peptides being released with low degrees of depolarization and greater amounts of the larger rnol wt forms being released with higher degrees of depolarization (1 I).
The use of proteolytic digestion of plasma has been previously reported to substantially increase the yield of MET-ENKi (1 1,  22) . Investigators have shown that plasma treated with trypsin 54 MARTINEZ ET AL. and carboxypeptidase B yields MET-ENKi which coelutes with MET-ENK standard as well as carboxyl-extended forms of MET-ENK using gel filtration and HPLC (1 1, 2 1, 22 ). Attempts to characterize the substrates yielding immunoreactive products have shown contrasting results. Although the products of the digestion procedures have been shown to be immunologically and chromatographically identical to MET-ENK, treatment of rat plasma with pepsin, a more nonphysiologic proteolysis, also yields measurable levels of MET-ENK (23) . Generally, a relatively broad range of mol wt substrates from plasma have been shown to yield MET-ENKi after digestion with trypsin and carboxypeptidase b (1 1, 21, 22 ). This has been true in both developing and adult animals. Whether this represents digestion from multimeric forms of the proenkephalin proteins in circulation or nonspecific substrates deserves further careful study.
The physiologic role of opiate peptides has been the subject of many recent investigations. The opiate peptides and their receptors have been identified in CNS areas important for autonomic, cardiovascular, and respiratory control (3, 4), as well as in sympathetic ganglia (8) and the adrenal medulla (9, 10) . The colocalization of these peptides and their receptors has suggested a role as modulators of the sympathoadrenal system. Previous studies have shown the opiate peptides inhibit norepinephrine release in sympathetic ganglia through presynaptic inhibition of cholinergic transmission probably through reduced acetylcholine release (3, 6) . Opiate peptides have also been shown to inhibit adrenal catecholamine release in vitro in response to cholinergic stimulation (7) . Data in adult animals suggest the opiate peptides are involved in the circulatory function of animals under physiologic stress and are responsible for some of the deleterious cardiovascular changes seen in animals with hemorrhagic (4), endotoxic (24) (25) (26) , and spinal shock (4) . Numerous in vivo studies using opiate peptide antagonists have shown increases in circulating catecholamines, as well as improvement in blood pressure and circulatory function in different animal models during shock (25) (26) (27) (28) (29) . Similar findings have been reported in human newborns (30) . We have recently shown opiate receptor blockade with naloxone significantly augments epinephrine levels in fetal sheep exposed to hypoxia (17) .
In summary, our data taken together with previous observations, is consistent with the interpretation of cosecretion of the enkephalin peptides with catecholamines during periods of physiologic stress in the intact animal. These data also suggest incomplete processing of the large mol wt peptides occurs before secretion. Where further processing of these large mol wt en-kephalins occurs and where these circulating peptides exert their physiologic effect is unclear. Further work to determine the source of the circulating peptides, site of action, and whether the increased plasma levels of the enkephalin peptides represent increased secretion or simply altered clearance or metabolism remains to be examined.
